Emeritus Professor Graham Cooksley

Powell, L. W., Bassett, M. and Cooksley, W. G. E. (2006). Liver Function Tests in Abnormal Laboratory Results. Abnormal Laboratory Results. (pp. 88-94) edited by Geoffrey Kellerman. North Ryde, N.S.W.: McGraw-Hill.

Littlejohn, Margaret, Jaskowski, Lesley-Anne, Edwards, Ros, Jackson, Kathy, Yuen, Lilly, Crawford, Darrel, Locarnini, Stephen A. and Cooksley, Graham (2024). Molecular epidemiology of hepatitis B among Indigenous Australians in Queensland and the Torres Strait Islands. Internal Medicine Journal, 54 (1), 129-138. doi: 10.1111/imj.16166

McD Young, Ross, Lawford, Bruce, Mellor, Rebecca, Morris, Charles P, Voisey, Joanne, on behalf of the PTSD Initiative, McLeay, Sarah, Harvey, Wendy, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, McD Young, Ross, Dwyer, Miriam, Gibson, John, O'Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher, Thomson, Rachel, Voisey, Joanne and Lawford, Bruce (2021). Investigation of C reactive Protein and AIM2 Methylation as a marker for PTSD in Australian Vietnam veterans. Gene, 803 145898, 1-6. doi: 10.1016/j.gene.2021.145898

Akosile, Wole, Voisey, Joanne, Lawford, Bruce, Colquhoun, David, Young, Ross McD, Mehta, Divya, on behalf of the PTSD Initiative, McLeay, Sarah, Harvey, Wendy, Romaniuk, Madeline, Dwyer, Miriam, Gibson, John, O'Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher and Thomson, Rachel (2020). NLRP3 is associated with coronary artery disease in Vietnam veterans. Gene, 725 144163, 144163. doi: 10.1016/j.gene.2019.144163

Mehta, Divya, Pelzer, Elise S., Bruenig, Dagmar, Lawford, Bruce, McLeay, Sarah, Morris, Charles P., Gibson, John N., Young, Ross McD., Voisey, Joanne, Harvey, Wendy, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, Dwyer, Miriam, Gibson, John, O'Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher and Thomson, Rachel (2019). DNA methylation from germline cells in veterans with PTSD. Journal of Psychiatric Research, 116, 42-50. doi: 10.1016/j.jpsychires.2019.06.001

Theal, Rebecca, McLeay, Sarah, Gleeson, Sarah, Lowrie, Fraser, O'Sullivan, Robyn, on behalf of the PTSD Initiative, Harvey, Wendy, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, Young, Ross McD, Dwyer, Miriam, Gibson, John, Cooksley, Graham, Strakosch, Christopher, Thomson, Rachel, Voisey, Joanne and Lawford, Bruce (2019). Comparison of sleep patterns in Vietnam veterans with and without posttraumatic stress disorder using wrist actigraphy. Journal of Clinical Sleep Medicine, 15 (5), 725-732. doi: 10.5664/jcsm.7762

Kidd, Chloe, Romaniuk, Madeline, McLeay, Sarah, Harvey, Wendy, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, McD Young, Ross, Dwyer, Miriam, Gibson, John, O’Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher, Thomson, Rachel, Voisey, Joanne and Lawford, Bruce (2019). Resilience and psychopathology in trauma-exposed Australian Veterans: an exploratory factor analysis of the Connor-Davidson Resilience Scale. Journal of Military, Veteran and Family Health, 5 (1), 27-39. doi: 10.3138/jmvfh.2018-0016

Baird, Timothy, McLeay, Sarah, Harvey, Wendy, Theal, Rebecca, Law, Dayna, Romaniuk, Madeline, Crawford, Darrell, Colquhoun, David, Young, Ross, Dwyer, Miriam, Gibson, John, O'Sullivan, Robyn, Cooksley, Graham, Strakosch, Christopher, Thomson, Rachel, Voisey, Joanne and Lawford, Bruce (2018). Sleep disturbances in Australian Vietnam veterans with and without posttraumatic stress disorder. Journal of Clinical Sleep Medicine, 14 (5), 745-752. doi: 10.5664/jcsm.7096

McLeay, Sarah C., Harvey, Wendy M., Romaniuk, Madeline N. M., Crawford, Darrell H. G., Colquhoun, David M., Young, Ross McD., Dwyer, Miriam, Gibson, John M., O'Sullivan, Robyn A., Cooksley, Graham, Strakosch, Christopher R., Thomson, Rachel M., Voisey, Joanne and Lawford, Bruce R. (2017). Physical comorbidities of post-traumatic stress disorder in Australian Vietnam War veterans. Medical Journal of Australia, 206 (6), 251-257. doi: 10.5694/mja16.00935

Liaw, Yun-Fan, Kao, Jia-Horng, Piratvisuth, Teerha, Chan, Henry Lik Yuen, Chien, Rong-Nan, Liu, Chun-Jen, Gane, Ed, Locarnini, Stephen, Lim, Seng-Gee, Han, Kwang-Hyub, Amarapurkar, Deepak, Cooksley, Graham, Jafri, Wasim, Mohamed, Rosmawati, Hou, Jin-Lin, Chuang, Wan-Long, Lesmana, Laurentius A., Sollano, Jose D., Suh, Dong-Jin and Omata, Masao (2012). Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4). Hepatology International, 6 (4), 809-810. doi: 10.1007/s12072-012-9386-z

Liaw, Yun-Fan, Kao, Jia-Horng, Piratvisuth, Teerha, Chan, Henry Lik Yuen, Chien, Rong-Nan, Liu, Chun-Jen, Gane, Ed, Locarnini, Stephen, Lim, Seng-Gee, Han, Kwang-Hyub, Amarapurkar, Deepak, Cooksley, Graham, Jafri, Wasim, Mohamed, Rosmawati, Hou, Jin-Lin, Chuang, Wan-Long, Lesmana, Laurentius A., Sollano, Jose D., Suh, Dong-Jin and Omata, Masao (2012). Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatology International, 6 (3), 531-561. doi: 10.1007/s12072-012-9365-4

Graham Cooksley, W. (2011). Hepatitis B genotypes: Role of testing in clinical practice. Current Hepatitis Reports, 10 (2), 79-86. doi: 10.1007/s11901-011-0097-z

Swain, Mark G., Lai, Ming-Yang, Shiffman, Mitchell L., Cooksley, W. Graham E., Zeuzem, Stefan, Dieterich, Douglas T., Abergel, Armand, Pessoa, Mario G., Lin, Amy, Tietz, Andreas, Connell, Edward V. and Diago, Moises (2010). A sustained virologic response is durable in patients with chronic hepatitis C treated with peginterferon alfa-2a and ribavirin. Gasteroenterology, 139 (5), 1593-1601. doi: 10.1053/j.gastro.2010.07.009

Cooksley, W. G. E. (2010). Do we need to determine viral genotype in treating chronic hepatitis B?. Journal of Viral Hepatitis, 17 (9), 601-610. doi: 10.1111/j.1365-2893.2010.01326.x

Cooksley, William Graham Earnshaw (2010). Natural history of chronic hepatitis B: Extending the REVEAL study. Liver International, 30 (8), 1085-1086. doi: 10.1111/j.1478-3231.2010.02277.x

Cooksley, G., AI463026 Benefits of Entecavir for Hepatitis B Liver Disease (BEHoLD) Study Group and et al. (2008). Entecavir therapy for lamivudine-refractory chronic hepatitis B: Improved virologic, biochemical, and serology outcomes through 96 weeks. Hepatology, 48 (1), 99-108. doi: 10.1002/hep.22323

Fried, Michael W., Piratvisuth, Teerha, Lau, George K. K., Marcellin, Patrick, Chow, Wan-Cheng, Cooksley, Graham, Luo, Kang-Xian, Paik, Seung Woon, Liaw, Yun-Fan, Button, Peter and Popescu, Matei (2008). HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology, 47 (2), 428-434. doi: 10.1002/hep.22065

Roberts, Stuart K., Cooksley, Graham, Dore, Gregory J., Robson, Richard, Shaw, David, Berns, Heather, Hill, George, Klumpp, Klaus, Najera, Isabel and Washington, Carla (2008). Robust antiviral activity of R1626, a novel nucleoside analog: A randomized, placebo-controlled study in patients with chronic Hepatitis C. Hepatology, 48 (2), 398-406. doi: 10.1002/hep.22321

Vandepapeliere, Pierre, Lau, George K.K., Leroux-Roels, Geert, Horsmans, Yves, Gane, Edward, Tawandee, Tawesak, Merican, Mohd Ismail bin, Win, Khin Maung, Trepo, Christian, Cooksley, Graham, Wettendorff, Martine, Ferrari, Carlo and The Therapeutic HBV Vaccine Group of Investigators (2007). Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: A randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine. Vaccine, 25 (51), 8585-8597. doi: 10.1016/j.vaccine.2007.09.072

Morice, Yoann, Cantaloube, Jean-Francois, Beaucourt, Stephanie, Barbotte, Laetitia, De Gendt, Sija, Lopes Goncales, Fernando, Butterworth, Lesley, Cooksley, Graham, Gish, Robert G., Beaugrand, Michel, Fay, Fabian, Fay, Oscar, Gonzalez, Jorge E., Martins, Regina Maria Bringel, Dhumeaux, Daniel, Vanderborght, Bart, Stuyver, Lieven, Sablon, Erwin, de Lamballerie, Xavier and Pawlotsky, Jean-Michel (2006). Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. Journal of Medical Virology, 78 (10), 1296-1303. doi: 10.1002/jmv.20692

Conrad, S., Garrett, L. E., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006). Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness, 2 (2), 121-131. doi: 10.1177/17423953060020020701

Perrillo, Robert P., Gish, Robert G., Peters, Marion, Keeffe, Emmet B., Alberti, Alfredo, Buti, Maria, Cooksley, W. Graham E., Fried, Michael W., Hadziyannis, Stephanos J., Liaw, Yun–Fan, Naoumov, Nikolai V., Schiff, Eugene R., Thio, Chloe L., Tsai, Naoky and Schalm, Solko (2006). Chronic hepatitis B: A critical appraisal of current approaches to therapy. Clinical Gastroenterology And Hepatology, 4 (2), 233-248. doi: 10.1016/S1542-3565(05)00983-3

Berg, C., Goncales, F. L., Bernstein, D. E., Sette, H., Rasenack, J., Diago, M., Jensen, D. M., Graham, P. and Cooksley, William G.E. (2006). Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin. Journal Of Viral Hepatitis, 13 (7), 435-440. doi: 10.1111/j.1365-2893.2006.00727.x

Lang, C. A., Conrad, S., Garrett, L., Battistutta, D., Cooksley, W. G. E., Dunne, M. P. and Macdonald, G. A. (2006). Symptom prevalence and clustering of symptoms in people living with chronic hepatitis C infection. Journal of Pain And Symptom Management, 31 (4), 335-344. doi: 10.1016/j.jpainsymman.2005.08.016

Hui, A. Y., Chan, H. L.-Y., Cheung, A. Y.-K., Cooksley, G. and Sung, J. J.-Y. (2005). Systematic review: Treatment of chronic hepatitis B virus infection by pegylated interferon. Alimentary Pharmacology and Therapeutics, 22 (6), 519-528. doi: 10.1111/j.1365-2036.2005.02616.x

Cooksley, W. Graham E. (2005). Peginterferon-alpha 2a for the Treatment of Hepatitis B Infection. Expert Opinion on Pharmacotherapy, 6 (8), 1373-1380. doi: 10.1517/14656566.6.8.1373

Cooksley, William G. E. (2005). Therapies for Viral Hepatitis Workshop. I Drugs, 8 (2), 124-126.

Lau, George, K. K., Piratvisuth, Teerha, Luo, Kang Xian, Marcellin, Patrick, Thongsawat, Satawat, Cooksley, Graham, Gane, Edward, Fried, Michael, W., Chow, Wan Cheng, Paik, Seung Woon, Chang, Wen Yu, Berg, Thomas, Flisiak, Robert, McCloud, Philip and Pluck, Nigel (2005). Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B. New England Journal of Medicine, 352 (26), 2682-2695. doi: 10.1056/NEJMoa043470

Cooksley, G. (2005). Does the Addition of Lamivudine to Peginterferon a-2a sustain Response Rates in Patients with HBeAG Negative Hepatitis B?. Nature Clinical Practice. Gastroenterology & Hepatology, 2 (1), 12-13. doi: 10.1038/ncpgasthep0068

John, T. J. and Cooksley, William G. E. (2005). Hepatitis B vaccine boosters: Is there a clinical need in high endemicity populations?. Journal of Gastroenterology and Hepatology, 20 (1), 5-10. doi: 10.1111/j.1440-1746.2004.03398.x

Cooksley, William G.E. (2005). Pegylated Interferons in Chronic HBV: Alone or As Combination Therapy. Current Hepatitis Reports, 4 (1), 34-38. doi: 10.1007/s11901-005-0024-2

Cooksley, G. (2005). Optimising treatment of hepatitis C. Romanian Journal of Gastroenterology, 14 (Supplement 17)

Jazayeri, Mohammed S., Basuni, Ashraf A., Cooksley, Graham, Locarnini, Stephen and Carman, William F. (2004). Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region. Journal of Hepatology, 41 (1), 139-146. doi: 10.1016/j.jhep.2004.03.025

Cooksley, G. (2004). The importance and benefits of hepatitis A prevention in chronic liver disease patients. Journal of Gastroenterology And Hepatology, 19 (Suppl), S17-S20. doi: 10.1111/j.1440-1746.2003.03394.x

Basuni, A. A., Butterworth, L., Cooksley, G., Locarnini, S. and Carman, W. F. (2004). Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine, 22 (21-22), 2791-2799. doi: 10.1016/j.vaccine.2004.01.046

Sullivan, S. D., Jensen, M., Bernstein, D. E., Hassanein, T. I., Foster, G. R., Lee, S. S., Cheinquer, H., Craxi, A., Cooksley, G., Klaskala, W., Pettit, K., Patel, K. K. and Green, J. (2004). Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C. American Journal of Gastroenterology, 99 (8), 1490-1496. doi: 10.1111/j.1572-0241.2004.30286.x

Jazayeri, M., Basuni, A. A., Sran, N., Gish, R., Cooksley, G., Locarnini, S. and Carman, W. F. (2004). HBV core sequence: definition of genotype-specific variability and correlation with geographical origin. Journal of Viral Hepatitis, 11 (6), 488-501. doi: 10.1111/j.1365-2893.2004.00534.x

Cooksley, W. G. (2004). The role of interferon therapy in hepatitis B. Medscape General Medicine, 6 (1), 16-16.

Hassanein, T., Cooksley, G., Sulkowski, M., Smith, C., Marinos, G., Lai, M-Y., Pastore, G., Trejo-Estrada, R., Horta e Vale, A., Wintfeld, N. and Green, J. (2004). The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. Journal of Hepatology, 40 (4), 675-681. doi: 10.1016/j.jhep.2003.12.014

Cooksley, W.G. (2004). Treatment of hepatitis B with interferon and combination therapy. Clinics in Liver Disease, 8 (2), 353-370. doi: 10.1016/j.cld.2004.02.004

Craxi, A. and Cooksley, W. G. (2003). Pegylated Interferons for Chronic Hepatitis B. Antiviral research, 60 (2), 87-89. doi: 10.1016/j.antiviral.2003.08.015

Van Damme, Pierre, Banatvala, J., Fay, O., Iwarson, S., McMahon, B., Van Herck, K., Shouval, D., Bonanni, P., Connor, B., Cooksley, G., Leroux-Roels, G., Von Sonnenburg, F. and International Consensus Group on Hepatitis A Virus Immunity (2003). Hepatitis A booster vaccination: is there a need?. Lancet, 362 (9389), 1065-1071. doi: 10.1016/S0140-6736(03)14418-2

Cooksley, William G.E., Piratvisuth, T., Lee, S.-D., Mahachai, V., Chao, Y.-C., Tanwandee, T., Chutaputti, A., Yu Chang, W., Zahm, F. E. and Pluck, N. (2003). Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. Journal of Viral Hepatitis, 10 (4), 298-305. doi: 10.1046/j.1365-2893.2003.00450.x

Ladhams, A., Schmidt, C., Sing, G., Butterworth, L., Fielding, G., Tesar, P., Strong, R., Leggett, B., Powell, L., Maddern, G., Ellem, K. and Cooksley, G. (2002). Treatment of non-resectable hepatocellular carcinoma with autologous tumor-pulsed dendritic cells. Journal of Gastroenterology And Hepatology, 17 (8), 889-896. doi: 10.1046/j.1440-1746.2002.02817.x

Sugauchi, F., Mizokami, M., Orito, E., Ohno, T., Kato, H., Suzuki, S., Kimura, Y., Ueda, R., Butterworth, L. A. and Cooksley, W. G. E. (2001). A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. Journal of General Virology, 82 (4), 883-892.

Sing, G., Li, D., Chen, X., Macnaughton, T. B., Lichanska, A., Butterworth, L. A., Ladhams, A. and Cooksley, W. G. E. (2001). A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: Evidence for antigen-driven selection of a public complementarity-determining region 3 (CDR3) motif. Hepatology, 33 (5), 1288-1298. doi: 10.1053/jhep.2001.24026

Sing, G. K., Ladhams, A., Arnold, S., Parmar, H., Chen, X., Cooper, J., Butterworth, L., Stuart, K., D'Arcy, D. and Cooksley, W. G. E. (2001). A longitudinal analysis of cytotoxic T lymphocyte precursor frequencies to the hepatitis B virus in chronically infected patients. Journal of Viral Hepatitis, 8 (1), 19-29. doi: 10.1046/j.1365-2893.2001.00260.x

Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G., Lee, S. S., Balart, L., Reindollar, R., Reddy, R., Wright, T., Lin, A., Hoffman, J. and De Pamphilis, J. (2000). Peginterferon Alfa-2a in Patients with Chronic Hepatitis C and Cirrhosis. New England Journal of Medicine, 343 (23), 1673-1680. doi: 10.1056/NEJM200012073432302

Schramm, T. M., Lawford, B., Macdonald, G. A. and Cooksley, W. G. E. (2000). Sertraline treatment of interferon-alfa-induced depressive disorder. Medical Journal of Australia, 173 (7), 359-361. doi: 10.5694/j.1326-5377.2000.tb125687.x

Cooksley, W. G. E. (2000). What did we learn from the Shanghai hepatitis A epidemic?. Journal of Viral Hepatitis, 7 (Suppl 1), 1-3. doi: 10.1046/j.1365-2893.2000.00021.x

Basuni, A. A., Butterworth, L. A., Cooksley, G., Locarnini, S. and Carman, W. F. (2000). An efficient extraction method from blood clots for studies requiring both host and viral DNA. Journal of Viral Hepatitis, 7 (3), 241-243.

Cooksley, W. G. E. (2000). Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease. Journal of Viral Hepatitis, 7 (Suppl 1), 29-30.

Cooksley, W. G. E. (1999). Natural history of Hepatitis C. Italian Journal of Gastroenterology and Hepatology, 31 (1), 1-3.

Bates, P. R., McCombe, P. A., Sheean, G. L., Cooksley, W. G. E. and Pender, M. P. (1993). Failure to Detect Measles Virus Sequences in Lymphocytes of Patients with Multiple Sclerosis. Australian and New Zealand Journal of Medicine, 23 (1), 55-55. doi: 10.1111/j.1445-5994.1993.tb00539.x

Soeharso, Purnomo , Summers, Kim M. and Cooksley, W. G. E. (1992). Allotype distribution of human T cell receptor β and γ chain genes in Caucasians, Asians and Australian Aborigines: Relevance to chronic hepatitis B. Human Genetics, 89 (1), 59-63. doi: 10.1007/BF00207043

Powell, Elizabeth E., Pender, Michael P., Chalk, Jonathan B., Parkin, Philip J., Strong, Russell, Lynch, Stephen, Kerlin, Paul, Cooksley, W. Graham, Cheng, Wendy and Powell, Lawrie W. (1990). Improvement in Chronic Hepatocerebral Degeneration Following Liver Transplantation. Gastroenterology, 98 (4), 1079-1082. doi: 10.1016/0016-5085(90)90036-Z

Cooksley, W. Graham E. , Bradbear, Robin A., Robinson, William, Harrison, Mark, Halliday, June W., Powell, Lawrie W., Ng, Han‐Seung, Seah, Chen‐Siang, Okuda, Kunio, Scheuer, Peter J. and Sherlock, Sheila (1986). The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology, 6 (3), 345-348. doi: 10.1002/hep.1840060302

Cooksley, W. G., Powell, L. W., Kerr, J. F. and Bhathal, P. S. (1972). Cholestasis in active chronic hepatitis. The American Journal of Digestive Diseases, 17 (6), 495-504. doi: 10.1007/BF02231204

Roberts, R., Cooksley, G., Shaw, D., Berns, H. K., Brandl, M. T., Fettner, S. H., Hill, G., Ipe, D., Klumpp, K., Mannino, M., O'Mara, E., Tuo, Y. and Washington, C. B. (2006). Interim results of a multiple ascending dose study of R1626, a novel nucleoside analog targeting HCV polymerase in chronic hcv patients. 41st Annual Meeting of the European Association for the Study of the Liver, Vienna, Austria, 26-30 April 2006. Amsterdam: Elesevier Science. doi: 10.1016/S0168-8278(06)80731-2

Cooksley, W. Graham (2004). Treatment with interferons (including pegylated interferons) in patients with hepatitis B. Scientific and Clinical Expert Panel Meeting on HBV Viral Kinetics and Clinical Management, Chicago, IL, U. S. A., 18 October, 2003. New York, N.Y. U.S.A.: Thieme-Stratton. doi: 10.1055/s-2004-828678

Cooksley, W. G. E., Lai, M-Y., Piratvisuth, T., Wang, Y-J., Mahachai, V., Chao, Y-C., Tanwandee, T., Chutaputti, A., Chang, W-Y, Zahm, F. E. and Pluck N. (2004). Peginterferon alfa-2A (PEGASYSA R): Efficacy in patients with difficult-to-treat HBV.. 11th International Symposium on Viral Hepatitis and Liver Disease (2003), Sydney, Australia, 6-10 April, 2003. Sydney: ACHV.

Cooksley, Graham (2003). The treatment of hepatitis B e antigen-positive chronic hepatitis B with pegylated interferon. EASL International Consensus Conference on Hepatitis B, Geneva, Switzerland, 13-14 September, 2002. ADIS PRESS AUSTRALASIA P/L. doi: 10.1016/S0168-8278(03)00327-1

Cooksley, W. G. E., Crawford, D., Gowans, E. J., Harrison, M., Lott, W. B., Macdonald, G. and Sloots, T. (2000). Effects of cobalamin on hepatitis C virus translation and replication. Ann Mtg of American Assn for the Study of Liver Disease, Dallas, Texas, 27-31 Oct, 2000.

Basuni, A. A., Butterworth, L. A., Cooksley, W. G. E., Locarnini, S. and Carman, W. F. (2000). Use of HBV surface antigen variability to confirm migration pattern hypothesis of Pacific peoples. Ann Mtg of American Assn for the Study of Liver Disease, Dallas, Texas, 27-31 Oct, 2000.

Cooksley, W. G. E. (2000). Effect of chronic hepatitis C on health-related quality of life. Digestive Diseases Week, San Diego, USA, 21-24 May, 2000.

Butterworth, L. A., Cooksley, W. G. E., Crawford, D., D'Arcy, D., Dorrington, L., Garrett, L., Hourigan, K., Macdonald, G. and Walker, D. (2000). Early detection of response to interferon treatment in chronic HCV. 10th Int Symp on Viral Hepatitis and Liver Disease, Atlanta, USA, 9-13 April, 2000.

Conrad, S., Macdonald, G., Garrett, L., Cooksley, W. G. E. and Dunne, M. P. (2000). Quality of life in chronic hepatitis C infection. American Association for the Study of Liver Disease, Dallas, Texas, 27-31 Ocobert, 2000. Hoboken, NJ: Wiley Interscience.

Mortimore, M, Francis, LP, Purdie, DM, Edwards, JT, Pandeya, N, Searle, J, Cooksley, G, Powell, LW and MacDonald, GA (2000). The relationship between hepatic steatosis and indices of obesity. 51st Annual Meeting American Association for the Study of Liver Disease, Dallas, Texas, 27-31 Oct, 2000. Hoboken, NJ: Wiley Interscience.

Pawlotsky, J. M., De Gendt, S., Beaucourt, S., Lopez Goncales, F., Butterworth, L. A. and Cooksley, W. G. E. (1999). Molecular epidemiology of hepatitis C virus genotype 3a in intravenous drug users (IVDUs). HCV Meeting, Bethesda, Maryland, April, 1999.

Heathcote, E. J., Shiffman, M. L., Cooksley, W. G. E., Dusheiko, G., Lee, S. S., Balart, R., Reindollar, R., Reddy, R., Wright, T. and DePamphilis, J. (1999). Multinational evaluation of the efficacy and safety of once-weekly peginterferon a-2a (PEG-IFN) in patients with chronic hepatitis C (CHC) with compensated cirrhosis. 50th Annual Meeting of the American Association for the Study of Liver Diseases, Wyndham Anatole Hotel, Dallas, 5-9 November, 1999. Alexandria, Vancouver: AASLD.

Carreno, V. and Cooksley, W. G. E. (1999). A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. 50th Annual Meeting of the American Association for the Study of Liver Diseases, Wyndham Anatole Hotel, Dallas, 5-9 November, 1999. Alexandria, Vancouver: AASLD.

Butterworth, L. A., Cooksley, W. G. E., Crawford, D., D'Arcy, D., Dorrington, L., Hourigan, K. and Walker, D. (1999). Early detection of sustained responders to Interferon treatment. 3rd International Conference on Therapies for Viral Hepatitis, Ritz Carlton, Maui, Hawaii, 12-16 December, 1999. Atlanta, Georgia: Int. Medical Press.

Shiffman, M. L., Heathcote, E. J., Pockros, P. J., Cooksley, W. G. E., Reddt, R. K., Dusheiko, G., Wright, T., Pedder, S., Hoffman, J. and Fried, M. (1999). Treatment of chronic hepatits C virus (HCV) infection with a modified form of Interferon alfa-2a (IFN) containing a branched, 40 kDa polyethylene glycol (PEG) moiety: virological results in patients with and without cirrhosis. 3rd International Conference on Therapies for Viral Hepatitis, Ritz Carlton, Maui, Hawaii, 12-16 December, 1999. Atlanta, Georgia: Int. Medical Press.

Emeritus Professor Graham Cooksley

Publications

Book Chapter

Journal Articles

Conference Papers